Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Medical ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Female sexual dysfunction.Med Clin North Am. 2015; 99: 607-628
- A comparison of DSM-IV-TR and DSM-5 definitions for sexual dysfunctions: critiques and challenges.J Sex Med. 2014; 11: 364-373
- Human sexual response.Little, Brown and Company, Boston1966
- Women’s endorsement of models of female sexual response: the nurses’ sexuality study.J Sex Med. 2007; 4: 708-719
- Conceptualizing women’s sexual function: linear vs. circular models of sexual response.J Sex Med. 2009; 6: 2761-2771
- Endorsement of models describing response of men and women with a sexual partner: an online survey in a population sample of Danish adults ages 20-65 years.J Sex Med. 2015; 12: 116-128
- Disentangling desire and arousal: a classificatory conundrum.Arch Sex Behav. 2013; 42: 1079-1100
- Should sexual desire and arousal disorders in women be merged?.Arch Sex Behav. 2011; 40: 217-219
- Proposal for changes in diagnostic criteria for sexual dysfunctions.J Sex Med. 2007; 4: 567-580
- Diagnostic and statistical manual of mental disorders: DSM- IV-TR.American Psychiatric Publishing, Washington, DC2000
- Diagnostic and statistical manual of mental disorders.5th edition. American Psychiatric Publishing, Arlington (VA)2013
- The development of the ICD-11 clinical descriptions and diagnostic guidelines for mental and behavioural disorders.World Psychiatry. 2015; 14: 82-90
- Disorders related to sexuality and gender identity in the ICD-11: revising the ICD-10 classification based on current scientific evidence, best clinical practices, and human rights considerations.World Psychiatry. 2016; 15: 205-221
- The sexual tipping point: a mind/body model for sexual medicine.J Sex Med. 2009; 6: 629-632
- Female sexual response: the role of drugs in the management of sexual dysfunction.Obstet Gynecol. 2001; 98: 350-353
- What can prevalence studies tell us about female sexual difficulty and dysfunction?.J Sex Med. 2006; 3: 589-595
- Recent and lifelong sexual dysfunction in female UK population sample: prevalence and risk factors.J Sex Med. 2001; 8: 2420-2430
- Sexual problems and distress in United States women: prevalence and correlates.Obstet Gynecol. 2008; 112: 970-978
- Sexual pleasures. Enhancement of sex life in Finland. 1971-1992.Aldershot Publishing, Dartmouth (NH)1995
- Incidence and persistence/recurrence of women’s sexual difficulties: findings from the Australian Longitudinal Study of Health and Relationships.J Sex Marital Ther. 2012; 38: 378-393
- Sexual disabilities and sexual problems.in: Fugl-Meyer K.S. Sex in Sweden. (pp 199). Swedish National Institute of Health, Stockholm (Sweden)2000
- Definitions of sexual dysfunctions in women and men: a consensus statement from the fourth International Consultation on Sexual Medicine 2015.J Sex Med. 2016; 13: 135-143
- An update on sexual function and dysfunction in women.Arch Womens Ment Health. 2015; 18: 423-433
- The female sexual response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire disorder.CNS Drugs. 2015; 29: 915-933
- Magnetic resonance imaging of male and female genitals during coitus and female sexual arousal.BMJ. 1999; 319: 1596-1600
- Hormone therapy for sexual function in perimenopausal and postmenopausal women.Cochrane Database Syst Rev. 2013; (CD009672)
- Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.Menopause. 2006; 13: 770
- The role of testosterone therapy in postmenopausal women: position statement of the North American Menopause Society.Menopause. 2005; 12: 496
- Androgens and female sexual function and dysfunction- findings from the fourth International Consultation of Sexual Medicine.J Sex Med. 2016; 13: 168-178
- An update on the pharmacological management of female sexual dysfunction.Expert Opin Pharmacother. 2012; 13: 2131-2142
- Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women.Menopause. 2003; 10: 390-398
- Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women.J Sex Med. 2008; 5: 132-138
- Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.Climacteric. 2001; 4: 314
- Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.J Sex Med. 2008; 5: 646-656
- Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial.Climacteric. 2015; 18: 226-232
- Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy.Menopause. 2013; 20: 623-630
- Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy.J Sex Med. 2014; 11: 487-497
- Flibanserin: a novel, nonhormonal agent for the treatment of hypoactive sexual desire disorder in premenopausal women.J Pharm Pract. 2016; ([Epub ahead of print])
- Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial.Menopause. 2014; 21: 633-640
- Efficacy and safety of flibanserin in women with hypoactive sexual desire disorder: a systematic review and meta-analysis.J Sex Med. 2015; 12: 2095-2104
- Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study.J Urol. 2003; 170: 2333-2338
- Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder.J Womens Health Gend Based Med. 2002; 11: 367-377
- Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study.BJOG. 2001; 108: 623-628
- Short- and long-term effects of Ginkgo biloba extract on sexual dysfunction in women.Arch Sex Behav. 2008; 37: 530-547
- The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status.J Sex Marital Ther. 2006; 32: 369-378
- Treating symptoms of female sexual arousal disorder with the Eros-Clitoral Therapy Device.J Gend Specif Med. 2001; 4: 54-58
- Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women.J Clin Psychopharmacol. 2004; 24: 339-342
- Characterization of orgasmic difficulties by women: focus group evaluation.J Sex Med. 2013; 10: 2242-2250
- Patterns of female arousal during sleep and waking: vaginal thermoconductance studies.Arch Sex Behav. 1983; 12: 97-122
- Nocturnal orgasms: females’ perception of a “normal” sexual experience.J Sex Res. 1983; 22: 412-437
- Functional MRI of the brain during orgasm in women.Annu Rev Sex Res. 2005; 16: 62-86
- Genetic influences on variation in female orgasmic function: a twin study.Biol Lett. 2005; 1: 260-263
- Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients.Neuropsychopharmacology. 2009; 34: 1819-1828
- Socio-cultural representations of the vagina.J Reprod Infant Psychol. 2001; 18: 17-32
- Genital appearance dissatisfaction: implications for women’s genital image self-consciousness, sexual esteem, sexual satisfaction, and sexual risk.Psychol Women Q. 2010; 34: 394-404
- The meaning of heterosexual intercourse among women with female orgasmic disorder.Arch Sex Behav. 2003; 32: 61-71
- Emotional intelligence and its association with orgasmic frequency in women.J Sex Med. 2009; 6: 1930-1937
- Understanding orgasmic difficulty in women.J Sex Med. 2016; 13: 1246-1254
- Sexual dysfunction in the United States: prevalence and predictors.JAMA. 1999; 281: 537-544
- A general look at female orgasm and anorgasmia.Sex Health. 2006; 3: 143-153
- Disorders of orgasm in women.in: Lue T.F. Basson R. Rosen R. Sexual dysfunctions in men and women. Health Publications, Paris2004 (Summary of Committee)
- Effect of tibolone on sexual function in late postmenopausal women.Folia Med (Plovdiv). 2007; 49: 41-48
- Women’s sexual pain disorders.J Sex Med. 2010; 7: 616-631
- Female sexual pain disorders: dyspareunia and vaginismus.Curr Opin Psychiatry. 2014; 27: 406-412
- A psychophysiological investigation of sexual arousal in women with lifelong vaginismus.J Sex Med. 2013; 42: 1605-1614
- Vulvodynia: assessment and treatment.J Sex Med. 2016; 13: 572-590
- The McGill Pain Questionnaire: major properties and scoring methods.Pain. 1975; 1: 277-299
- The pain catastrophizing scale: development and validation.Psychol Assess. 1995; 7: 524-532
- Fear avoidance and self-efficacy in relation to measure perceived self-efficacy in people with arthritis.Semin Arthritis Rheum. 1989; 32: 37-44
- Reliability and validity of the vulvar functional status questionnaire (VQ).J Womens Health Phys Therap. 2007; 31: 1605-1614
- Vulvar vestibulitis syndrome.J Reprod Med. 1987; 32: 110
- The tampon test for vulvodynia treatment outcomes research reliability construct validity, and responsiveness.Obstet Gynecol. 2009; 113: 825-832
- The use of vaginal estrogen in women with a history of estrogen-dependent breast cancer.Obstet Gynecol. 2016; 127: e93-e96
- Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study.Menopause. 2010; 17: 480-486
- A systematic review of the utility of antidepressant pharmacotherapy in the treatment of vulvodynia pain.J Sex Med. 2013; 10: 2497-2505
- Impact of male partner responses on sexual function in women with vulvodynia and their partners - a dyadic daily experience study.Health Psychol. 2014; 33: 823-831
- Automatic and deliberate affective associations with sexual stimuli in women with lifelong vaginismus before and after therapist aided exposure treatment.J Sex Med. 2014; 11: 786-799
- Therapist aided exposure for women with lifelong vaginismus: mediators of treatment outcome: a randomized waiting list control trial.J Sex Med. 2015; 12: 1807-1819
- Interventions for vaginismus.Cochrane Database Syst Rev. 2012; (CD001760)
- Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis.J Sex Med. 2012; 9: 1497-1507
- Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.J Clin Psychopharmacol. 2009; 29: 259-266
- Sexual dysfunction due to psychotropic medications.Psychiatr Clin North Am. 2016; 39: 427-463
- Major depressive disorder, antidepressants, and sexual dysfunction.J Clin Psychiatry. 2006; 67: 33-37
- Strategies for managing sexual dysfunction induced by antidepressant medication.Cochrane Database Syst Rev. 2013; (CD003382)
- Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors.J Clin Psychopharmacol. 1999; 19: 268-271
- Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial.JAMA. 2008; 300: 395-404
- Exercise improves sexual function in women taking antidepressants: results from a randomized crossover trial.Depress Anxiety. 2014; 31: 188-195
- Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors.Hum Psychopharmacol. 2008; 23: 321-326
- Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.J Sex Med. 2007; 4: 917-929
- Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.J Clin Psychiatry. 2006; 67: 736-746
- A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.J Clin Psychopharmacology. 2006; 26: 482-488
- Sexual function during bupropion or paroxetine treatment of major depressive disorder.Can J Psychiatry. 2006; 51: 234-242
- Prevalence of sexual dysfunction among newer antidepressants.J Clin Psychiatry. 2002; 63: 357-366
Article info
Footnotes
This article originally appeared in the Psychiatric Clinics of North America, Volume 40, Issue 2, June 2017.
E.M. Valladares Juarez has nothing to disclose. A.H. Clayton: Grants: Endoceutics, Inc.; Janssen; Sage Therapeutics; Takeda. Advisory Board Fee/Consultant Fee: Acadia; Alkermes; Allergan; AMAG Pharmaceuticals, Inc.; Fabre-Kramer; Lundbeck; Otsuka; Palatin Technologies; S1 Biopharma; Sage Therapeutics; Sprout Pharmaceuticals; Takeda. Royalties/Copyright: Ballantine Books/Random House; Changes in Sexual Functioning Questionnaire; Guilford Publications. Shares/Restricted Stock Units: Euthymics; S1 Biopharma.
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.
